Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial

Dutch Breast Canc Res Grp BOOG

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)675-685
Number of pages11
JournalBreast Cancer Research and Treatment
Volume180
Issue number3
DOIs
Publication statusPublished - Apr 2020

Keywords

  • Breast cancer
  • Tamoxifen
  • Aromatase inhibitor
  • Bone health
  • Osteoporosis
  • Bisphosphonates
  • Survival
  • Bone metastases
  • Distant recurrence-free survival
  • ZOLEDRONIC ACID
  • POSTMENOPAUSAL WOMEN
  • IN-VITRO
  • THERAPY
  • CELLS
  • RISK
  • CHEMOTHERAPY
  • METASTASIS
  • MECHANISMS
  • CLODRONATE

Cite this